➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
Express Scripts
Merck
Colorcon

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Patent: 7,427,471

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,427,471
Title:Modified \"S\" antibodies
Abstract: The invention relates to the field of antibodies, and particularly to modified antibodies, methods of preparing modified antibodies and uses thereof. More particularly, the invention relates to the preparation of more active IgG antibodies by the addition of an extra immunoglobulin domain to the constant region.
Inventor(s): Scallon; Bernard J. (Wayne, PA), Cai; Ann (West Chester, PA), Naso; Michael (Philadelphia, PA)
Assignee: Centocor, Inc. (Malvern, PA)
Application Number:10/454,948
Patent Claims:see list of patent claims

Details for Patent 7,427,471

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Centocor, Inc. (Malvern, PA) 2022-06-14 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Centocor, Inc. (Malvern, PA) 2022-06-14 search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05   Start Trial Centocor, Inc. (Malvern, PA) 2022-06-14 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05   Start Trial Centocor, Inc. (Malvern, PA) 2022-06-14 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Start Trial Centocor, Inc. (Malvern, PA) 2022-06-14 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Start Trial Centocor, Inc. (Malvern, PA) 2022-06-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Colorcon
Johnson and Johnson
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.